On the occassion of the ninth meeting of the Board of Heads of HERCA held on 31 May 2012, a new version of the dose passbook has been approved. The new version integrates the comments received through an stakeholder’s consultation launched and commen
On the occasion of its 9th meeting held in Córdoba, Spain, on 31 May 2012, HERCA has approved a “Position Paper on Screening” in the framework of the exposure of asymptomatic individuals in healthcare.
On the occassion of the ninth meeting of the Board of Heads of HERCA held on 31 May 2012, a new version of the dose passbook has been approved. The new version integrates the comments received through an stakeholder’s consultation launched and commen
The Association of the Heads of the European Radiological protection Competent Authorities (HERCA) and the Food and Drug Administration (FDA) through its Center for Devices and Radiological Health (CDRH) as part of the U.S. Department of Health and H
The Association of the Heads of the European Radiological protection Competent Authorities (HERCA) and the Food and Drug Administration (FDA) through its Center for Devices and Radiological Health (CDRH) as part of the U.S. Department of Health and H
The Association of the Heads of the European Radiological protection Competent Authorities (HERCA) and the Food and Drug Administration (FDA) through its Center for Devices and Radiological Health (CDRH) as part of the U.S. Department of Health and H
The Association of the Heads of the European Radiological protection Competent Authorities (HERCA) and the Food and Drug Administration (FDA) through its Center for Devices and Radiological Health (CDRH) as part of the U.S. Department of Health and H
At the occasion of its 8th meeting held in Bern on 8 December 2011, HERCA has approved a proposal for a patient release card after a therapeutic application of radionuclides. The card is a complementary document to the document “131I therapy: Patient
At the occasion of its 8th meeting held in Bern on 8 December 2011, HERCA has approved a proposal for a patient release card after a therapeutic application of radionuclides. The card is a complementary document to the document “131I therapy: Patient